文献速递外周血管介入DSA

乙烯-乙烯醇共聚物联合其他栓塞剂经皮及血管内治疗Ia型内漏的作用

The role of ethylene-vinyl alcohol copolymer in association with other embolic agents for the percutaneous and endovascular treatment of type Ia endoleak.
PubMed 文献 · Radiol Med · 2018-04-13

本研究评估乙烯-乙烯醇共聚物(Onyx)单独或联合其他材料栓塞治疗EVAR术后Ia型内漏的安全性、技术与临床成功率。5例患者中,3例合并包裹性破裂,技术成功率和临床成功率均为100%,无并发症;4例瘤囊直径稳定,1例缩小。作者认为Onyx或可作为常规治疗失败后Ia型内漏的合适栓塞剂。

要点

  • EVAR术后Ia型内漏伴瘤囊增大或包裹性破裂时,可考虑用Onyx栓塞。
  • 本组5例技术成功率和临床成功率均为100%,无并发症。
  • 4例瘤囊直径稳定,1例缩小;作者认为Onyx或为合适栓塞剂。

核心结论

  • Onyx或可被认为是EVAR术后Ia型内漏患者在常规治疗(如主动脉颈部 prolonged balloon inflation 或大裸支架置入)失败后的合适栓塞剂。

研究设计与样本

  • 单臂病例系列,5例EVAR术后Ia型内漏患者;其中3例有包裹性破裂;1例既往行近端袖套置入,3例紧急置入近端袖套后Ia型内漏仍持续,1例既往使用Ovation腹主动脉支架系统后直接行血管内治疗;栓塞剂为Onyx单独或联合胶、弹簧圈或n-丁基氰基丙烯酸酯。

诊断标准与关键数值

  • 技术成功率100%,临床成功率100%,无主要或次要并发症,包括非靶栓塞。

临床应用与阅片要点

  • 经股动脉入路为常规选择,1例失败后改经腰直接穿刺瘤囊完成;4例瘤囊直径稳定,1例缩小;作者认为Onyx或可作为常规治疗失败后Ia型内漏的合适栓塞剂。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate safety, technical and clinical success of embolization of type Ia endoleak (T1a EL) using ethylene-vinyl alcohol copolymer as embolic agent alone or in combination with other materials.

MATERIALS AND METHODS: Five patients presented T1a EL after endovascular repair of aortic aneurysms (EVAR) with radiological evidence of expanding sac size; in particular, three had contained rupture. In one patient, proximal cuff insertion was previously performed, in three patients proximal cuff was urgently inserted but T1a EL persisted; one patient, previously treated with Ovation Abdominal Stent Graft System, was directly proposed for endovascular treatment. In all cases, endovascular embolization was successfully performed and the transfemoral approach was always chosen; in one case it failed and translumbar approach by direct puncture of the sac was required. Used embolization agents were glue, ethylene-vinyl alcohol copolymer (Onyx) and coils in three cases, n-butyl cyanoacrylate and Onyx in one case, Onyx and coils in the last case.

RESULTS: Technical success rate was 100% as well as clinical success. No major or minor complication, including non-target embolization, was registered. Clinical success was 100% until today and the sac diameter remained stable in four patients and decreased in one.

CONCLUSIONS: Onyx may be considered a suitable embolic agent in the treatment of patients with type Ia endoleaks after EVAR, after failure of conventional treatments such as prolonged balloon inflation of the aortic neck or deployment of large bare stent.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Ierardi AM, Franchin M, Fontana F, et al. The role of ethylene-vinyl alcohol copolymer in association with other embolic agents for the percutaneous and endovascular treatment of type Ia endoleak. Radiol Med. 2018. PMID: 29654570. doi:10.1007/s11547-018-0885-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。